Dorsey & Whitney Trust’s Precigen PGEN Stock Holding History

Dorsey & Whitney Trust’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47,000	Closed	-$66.7K	–	628
2023 Q3	$66.7K	Hold	47,000	–	–	0.01%	573
2023 Q2	$54K	Hold	47,000	–	–	﹤0.01%	583
2023 Q1	$49.8K	Hold	47,000	–	–	﹤0.01%	569
2022 Q4	$71.4K	Hold	47,000	–	–	0.01%	562
2022 Q3	$100K	Hold	47,000	–	–	0.01%	529
2022 Q2	$63K	Hold	47,000	–	–	0.01%	534
2022 Q1	$99K	Buy	47,000 +6,580	+16%	+$16K	0.01%	557
2021 Q4	$150K	Hold	40,420	–	–	0.01%	544
2021 Q3	$202K	Hold	40,420	–	–	0.02%	511
2021 Q2	$264K	Hold	40,420	–	–	0.03%	433
2021 Q1	$278K	Hold	40,420	–	–	0.03%	405
2020 Q4	$412K	Hold	40,420	–	–	0.05%	276
2020 Q3	$141K	Hold	40,420	–	–	0.02%	410
2020 Q2	$202K	Hold	40,420	–	–	0.03%	394
2020 Q1	$137K	Hold	40,420	–	–	0.02%	367
2019 Q4	$222K	Hold	40,420	–	–	0.03%	395
2019 Q3	$231K	Hold	40,420	–	–	0.03%	357
2019 Q2	$310K	Buy	40,420 +16,330	+68%	+$87.9K	0.05%	284
2019 Q1	$127K	Buy	+24,090	New	+$167K	0.02%	388

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dorsey & Whitney Trust's PGEN Position: Q4 2023 in Review

Dorsey & Whitney Trust sold out of Precigen (PGEN) in Q4 2023, closing a stake of 47,000 shares — an estimated $66.7K sold.

Dorsey & Whitney Trust first reported a position in PGEN in Q1 2019 and held it in 19 quarters. The position peaked at $412K in Q4 2020. 137 funds tracked by Wall St. Rank hold PGEN as of Q4 2023.

Dorsey & Whitney Trust reported no remaining Precigen position as of Q4 2023 after selling out during the quarter.
Dorsey & Whitney Trust sold 47,000 Precigen shares in Q4 2023, an estimated $66.7K.
Dorsey & Whitney Trust first reported a position in Precigen in Q1 2019 and held it in 19 quarters.
Dorsey & Whitney Trust's Precigen position peaked at $412K in Q4 2020.
137 funds tracked by Wall St. Rank held Precigen as of Q4 2023.

Based on Dorsey & Whitney Trust's 13F filing for Q4 2023, filed 12 Feb 2024.